Company page
Xortx Therapeutics, Inc.
Xortx Therapeutics, Inc. is a public company traded on the Canadian market under the ticker XRTX. The company has a market capitalization of approximately CAD 3.63 million. Xortx focuses on developing therapies for kidney diseases and related conditions.
- Ticker
- XRTX:TSXV
- Asset type
- Stock
- Market cap
- $3.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSXV
- Currency
- CAD